MACQUARIE GROUP LTD - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2022$4,000
-20.0%
0
-100.0%
0.00%
Q2 2022$5,000
-37.5%
2880.0%0.00%
Q1 2022$8,000
-27.3%
2880.0%0.00%
Q4 2021$11,000
-21.4%
2880.0%0.00%
Q3 2021$14,000
+40.0%
2880.0%0.00%
Q2 2021$10,000
-16.7%
2880.0%0.00%
Q1 2021$12,000
-33.3%
288
-32.1%
0.00%
Q4 2020$18,0000.0%4240.0%0.00%
Q3 2020$18,000
-10.0%
4240.0%0.00%
Q2 2020$20,000
-31.0%
424
-80.0%
0.00%
Q1 2020$29,0002,1250.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders